CLEARSIDE BIOMEDICAL INC (CLSD) Stock Analyst Earnings Estimates
NASDAQ:CLSD - Nasdaq - US1850631045 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.33M -95.50% | 8.226M 518.50% | 1.664M -79.77% | 4.049M 143.33% | 3.791M -6.37% | 14.819M 290.90% | 67.019M 352.25% | 145.91M 117.71% | 254.54M 74.45% | 259.92M 2.11% | 335.36M 29.02% | |
| EBITDA YoY % growth | -30.13M -6,747.73% | -24.777M 17.77% | -28.656M -15.66% | -33.61M -17.29% | -83.032M -147.05% | -66.906M 19.42% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30.28M -4,783.87% | -24.844M 17.95% | -28.882M -16.25% | -27.961M 3.19% | -48.963M -75.12% | -63.155M -28.98% | -20.509M 67.53% | 36.035M 275.70% | 116.08M 222.13% | 156.79M 35.07% | 222.16M 41.69% | |
| Operating Margin | -2,276.69% | -302.02% | -1,735.70% | -690.56% | -1,291.57% | -426.17% | -30.60% | 24.70% | 45.60% | 60.32% | 66.25% | |
| EPS YoY % growth | -0.55 -5,400.00% | -0.53 3.64% | -0.45 15.09% | -0.42 7.71% | -0.62 -49.97% | -0.51 18.11% | -0.16 69.50% | 0.28 280.33% | 0.90 219.09% | 1.27 42.07% | 1.63 27.80% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 -4.48% | -0.08 20.44% | -0.14 -38.42% | -0.20 -84.53% | -0.27 -157.74% | -0.30 -271.79% | -0.29 -112.22% |
| Revenue Q2Q % growth | 173.4K 92.67% | 173.4K -83.29% | 654.259K 113.81% | 102K -95.62% | 9.09M 5,142.21% | 9.136M 5,168.74% | 9.182M 1,303.42% |
| EBITDA Q2Q % growth | -7.399M 1.58% | -2.937M 49.26% | -14.213M -105.30% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.562M 13.54% | -6.104M -2.87% | -9.257M -29.49% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.11 26.67% | -0.11 | 0.00 | 0.67% |
| Q4 2024 Q2Q % growth | -0.10 -25.00% | -0.10 | 0.00 | -0.93% |
| Q3 2024 Q2Q % growth | -0.10 33.33% | -0.13 | 0.03 | 21.12% |
| Q2 2024 Q2Q % growth | -0.10 33.33% | -0.14 | 0.04 | 27.38% |
| Q1 2024 Q2Q % growth | -0.15 | -0.14 | -0.01 | -6.87% |
| Q4 2023 Q2Q % growth | -0.08 50.00% | -0.09 | 0.01 | 10.36% |
| Q3 2023 Q2Q % growth | -0.15 -15.38% | -0.16 | 0.01 | 5.12% |
| Q2 2023 Q2Q % growth | -0.15 -15.38% | -0.14 | -0.01 | -3.80% |
| Q1 2023 Q2Q % growth | -0.15 -15.38% | -0.14 | -0.01 | -5.04% |
| Q4 2022 Q2Q % growth | -0.16 -151.61% | -0.13 | -0.03 | -24.49% |
| Q3 2022 Q2Q % growth | -0.13 -62.50% | -0.03 | -0.10 | -274.86% |
| Q2 2022 Q2Q % growth | -0.13 -18.18% | -0.13 | 0.00 | 3.45% |
| Q1 2022 Q2Q % growth | -0.13 | -0.08 | -0.05 | -55.43% |
| Q4 2021 Q2Q % growth | 0.31 321.43% | 0.16 | 0.15 | 91.95% |
| Q3 2021 Q2Q % growth | -0.08 -60.00% | -0.09 | 0.01 | 7.73% |
| Q2 2021 Q2Q % growth | -0.11 15.38% | -0.13 | 0.02 | 15.96% |
| Q1 2021 Q2Q % growth | -0.13 -85.71% | -0.10 | -0.03 | -30.05% |
| Q4 2020 Q2Q % growth | -0.14 -100.00% | -0.12 | -0.02 | -20.40% |
| Q3 2020 Q2Q % growth | -0.05 70.59% | -0.12 | 0.07 | 57.98% |
| Q2 2020 Q2Q % growth | -0.13 40.91% | -0.12 | -0.01 | -7.49% |
| Q1 2020 Q2Q % growth | -0.07 84.44% | -0.12 | 0.05 | 39.80% |
| Q4 2019 Q2Q % growth | -0.07 | -0.07 | 0.00 | 6.41% |
| Q3 2019 Q2Q % growth | -0.17 | -0.16 | -0.01 | -4.17% |
| Q2 2019 Q2Q % growth | -0.22 | -0.40 | 0.18 | 45.05% |
| Q1 2019 Q2Q % growth | -0.45 | -0.41 | -0.04 | -9.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 2.33M 913.04% | 173.4K | 2.157M | 1,243.71% |
| Q4 2024 Q2Q % growth | 306K -95.18% | 180.203K | 125.797K | 69.81% |
| Q3 2024 Q2Q % growth | 1.038M 20.84% | 125.317K | 912.683K | 728.30% |
| Q2 2024 Q2Q % growth | 90K -91.16% | 129.203K | -39.203K | -30.34% |
| Q1 2024 Q2Q % growth | 230K 5,650.00% | 596.7K | -366.7K | -61.45% |
| Q4 2023 Q2Q % growth | 6.345M 1,822.73% | 4.522M | 1.823M | 40.31% |
| Q3 2023 Q2Q % growth | 859K 218.15% | 163.373K | 695.627K | 425.79% |
| Q2 2023 Q2Q % growth | 1.018M 167.89% | 126.684K | 891.316K | 703.57% |
| Q1 2023 Q2Q % growth | 4K -98.86% | 146.88K | -142.88K | -97.28% |
| Q4 2022 Q2Q % growth | 330K -98.72% | 97.92K | 232.08K | 237.01% |
| Q3 2022 Q2Q % growth | 270K -91.21% | 6.648M | -6.378M | -95.94% |
| Q2 2022 Q2Q % growth | 380K -51.28% | 382.5K | -2.5K | -0.65% |
| Q1 2022 Q2Q % growth | 350K 1,066.67% | 2.933M | -2.583M | -88.07% |
| Q4 2021 Q2Q % growth | 25.69M 256,800.00% | 18.127M | 7.563M | 41.72% |
| Q3 2021 Q2Q % growth | 3.07M -10.50% | 2.629M | 441K | 16.77% |
| Q2 2021 Q2Q % growth | 780K 122.86% | 589.733K | 190.267K | 32.26% |
| Q1 2021 Q2Q % growth | 30K -99.27% | 2.165M | -2.135M | -98.61% |
| Q4 2020 Q2Q % growth | 10K -99.48% | 1.316M | -1.306M | -99.24% |
| Q3 2020 Q2Q % growth | 3.43M 2,350.00% | 1.548M | 1.882M | 121.58% |
| Q2 2020 Q2Q % growth | 350K 600.00% | 1.359M | -1.009M | -74.25% |
| Q1 2020 Q2Q % growth | 4.1M 8,100.00% | 2.04M | 2.06M | 100.98% |
| Q4 2019 Q2Q % growth | 1.94M | 3.73M | -1.79M | -47.99% |
| Q3 2019 Q2Q % growth | 140K | 15.3K | 124.7K | 815.03% |
| Q2 2019 Q2Q % growth | 50K | 6.559K | 43.441K | 662.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.9% | 6.88% | 2.4% | 5% |
| Revenue | -1.92% | 0% | 51.59% | 382.42% |